{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:30:47Z","timestamp":1790379047718,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PID2020-119792RB-I00"],"award-info":[{"award-number":["PID2020-119792RB-I00"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Spain Ministry of Science Innovation and Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ymthe.2025.11.023","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T11:17:25Z","timestamp":1763637445000},"page":"2293-2308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Base edited skin equivalents with clinical potential for ex vivo correction of recessive dystrophic epidermolysis bullosa"],"prefix":"10.1016","volume":"34","author":[{"given":"Alex","family":"Bassons-Bascu\u00f1ana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estela","family":"M\u00e9ndez-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ugalde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Sanabria-Betri\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clotilde","family":"Aussel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Pe\u00f1a-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Olalla-Sastre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Ammann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni","family":"Cathomen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Del Rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"R\u00edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6771-3561","authenticated-orcid":false,"given":"Fernando","family":"Larcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"L\u00f3pez-Manzaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.11.023_bib1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41572-020-0210-0","article-title":"Epidermolysis bullosa","volume":"6","author":"Bardhan","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ymthe.2025.11.023_bib2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2147\/TCRM.S386923","article-title":"Innovations in the Treatment of Dystrophic Epidermolysis Bullosa (DEB): Current Landscape and Prospects","volume":"19","author":"Hou","year":"2023","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.ymthe.2025.11.023_bib3","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.3390\/ijms25042243","article-title":"Emerging Gene Therapeutics for Epidermolysis Bullosa under Development","volume":"25","author":"Bischof","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.11.023_bib4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/bjd\/ljad433","article-title":"Beremagene geperpavec (B-VEC) gene therapy for the treatment of cutaneous wounds in patients with dystrophic epidermolysis bullosa: a critically appraised research paper","volume":"190","author":"Doolan","year":"2024","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ymthe.2025.11.023_bib5","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ymthe.2019.03.007","article-title":"Clinically Relevant Correction of Recessive Dystrophic Epidermolysis Bullosa by Dual sgRNA CRISPR\/Cas9-Mediated Gene Editing","volume":"27","author":"Bonafont","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.11.023_bib6","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/j.jid.2020.02.012","article-title":"Predictable CRISPR\/Cas9-Mediated COL7A1 Reframing for Dystrophic Epidermolysis Bullosa","volume":"140","author":"Kocher","year":"2020","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ymthe.2025.11.023_bib7","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.jid.2019.02.015","article-title":"Efficient Gene Reframing Therapy for Recessive Dystrophic Epidermolysis Bullosa with CRISPR\/Cas9","volume":"139","author":"Takashima","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ymthe.2025.11.023_bib8","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1016\/j.ymthe.2017.07.005","article-title":"COL7A1 Editing via CRISPR\/Cas9 in Recessive Dystrophic Epidermolysis Bullosa","volume":"25","author":"Hainzl","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.11.023_bib9","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.omtn.2018.06.008","article-title":"Ex Vivo COL7A1 Correction for Recessive Dystrophic Epidermolysis Bullosa Using CRISPR\/Cas9 and Homology-Directed Repair","volume":"12","author":"Izmiryan","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2025.11.023_bib10","doi-asserted-by":"crossref","first-page":"26846","DOI":"10.1073\/pnas.1907081116","article-title":"CRISPR\/Cas9-based targeted genome editing for correction of recessive dystrophic epidermolysis bullosa using iPS cells","volume":"116","author":"Jack\u00f3w","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.11.023_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/npjregenmed.2016.14","article-title":"CRISPR\/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa","volume":"1","author":"Webber","year":"2016","journal-title":"NPJ Regen. Med."},{"key":"10.1016\/j.ymthe.2025.11.023_bib12","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.ymthe.2021.02.019","article-title":"Correction of recessive dystrophic epidermolysis bullosa by homology-directed repair-mediated genome editing","volume":"29","author":"Bonafont","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.11.023_bib13","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.jid.2023.10.035","article-title":"Highly Efficient Ex Vivo Correction of COL7A1 through Ribonucleoprotein-Based CRISPR\/Cas9 and Homology-Directed Repair to Treat Recessive Dystrophic Epidermolysis Bullosa","volume":"144","author":"Berthault","year":"2024","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ymthe.2025.11.023_bib14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.omtn.2021.05.015","article-title":"A non-viral and selection-free COL7A1 HDR approach with improved safety profile for dystrophic epidermolysis bullosa","volume":"25","author":"Kocher","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2025.11.023_bib15","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","article-title":"Genome editing with CRISPR\u2013Cas nucleases, base editors, transposases and prime","volume":"38","author":"Anzalone","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.11.023_bib16","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41587-021-01133-w","article-title":"Programmable deletion, replacement, integration and inversion of large DNA sequences with twin prime editing","volume":"40","author":"Anzalone","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.11.023_bib17","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jid.2019.07.701","article-title":"Base Editor Correction of COL7A1 in Recessive Dystrophic Epidermolysis Bullosa Patient-Derived Fibroblasts and iPSCs","volume":"140","author":"Osborn","year":"2020","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ymthe.2025.11.023_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-24184-8","article-title":"ABE8e adenine base editor precisely and efficiently corrects a recurrent COL7A1 nonsense mutation","volume":"12","author":"Sheriff","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.11.023_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2023.100191","article-title":"Cytosine Deaminase Base Editing to Restore COL7A1 in Dystrophic Epidermolysis Bullosa Human: Murine Skin Model","volume":"3","author":"Naso","year":"2023","journal-title":"JID Innov."},{"key":"10.1016\/j.ymthe.2025.11.023_bib20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.omtn.2018.01.009","article-title":"Deletion of a Pathogenic Mutation-Containing Exon of COL7A1 Allows Clonal Gene Editing Correction of RDEB Patient Epidermal Stem Cells","volume":"11","author":"Menc\u00eda","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2025.11.023_bib21","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1177\/0963689719857657","article-title":"Collagen VII Expression Is Required in Both Keratinocytes and Fibroblasts for Anchoring Fibril Formation in Bilayer Engineered Skin Substitutes","volume":"28","author":"Supp","year":"2019","journal-title":"Cell Transpl."},{"key":"10.1016\/j.ymthe.2025.11.023_bib22","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.2353\/ajpath.2009.090347","article-title":"Keratinocyte-\/fibroblast-targeted rescue of Col7a1-disrupted mice and generation of an exact dystrophic epidermolysis bullosa model using a human COL7A1 mutation","volume":"175","author":"Ito","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2025.11.023_bib23","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1126\/science.adk9428","article-title":"In vivo editing of lung stem cells for durable gene correction in mice","volume":"384","author":"Sun","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.11.023_bib24","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s40123-023-00729-6","article-title":"ABE8e Corrects Pax6-Aniridic Variant in Humanized Mouse ESCs and via LNPs in Ex Vivo Cortical Neurons","volume":"12","author":"Adair","year":"2023","journal-title":"Ophthalmol. Ther."},{"key":"10.1016\/j.ymthe.2025.11.023_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-34479-z","article-title":"Adenine base editing efficiently restores the function of Fanconi anemia hematopoietic stem and progenitor cells","volume":"13","author":"Siegner","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.11.023_bib26","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1365-2133.2009.09333.x","article-title":"Forty-two novel COL7A1 mutations and the role of a frequent single nucleotide polymorphism in the MMP1 promoter in modulation of disease severity in a large European dystrophic epidermolysis bullosa cohort","volume":"161","author":"Kern","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ymthe.2025.11.023_bib27","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/exd.12203","article-title":"Keratinocyte cell lines derived from severe generalized recessive Epidermolysis Bullosa patients carrying a highly recurrent COL7A1 homozygous mutation: models to assess cell and gene therapies in vitro and in vivo","volume":"22","author":"Chamorro","year":"2013","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ymthe.2025.11.023_bib28","doi-asserted-by":"crossref","first-page":"W242","DOI":"10.1093\/nar\/gky354","article-title":"CRISPOR: Intuitive guide selection for CRISPR\/Cas9 genome editing experiments and screens","volume":"46","author":"Concordet","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2025.11.023_bib29","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1042\/ETLS20180148","article-title":"CRISPR\/Cas9 gene editing for genodermatoses: progress and perspectives","volume":"3","author":"Naso","year":"2019","journal-title":"Emerg. Top. Life Sci."},{"key":"10.1016\/j.ymthe.2025.11.023_bib30","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1016\/j.ymthe.2022.06.005","article-title":"Therapeutic base editing and prime editing of COL7A1 mutations in recessive dystrophic epidermolysis bullosa","volume":"30","author":"Hong","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.11.023_bib31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1172\/JCI115557","article-title":"Type VII collagen gene expression by cultured human cells and in fetal skin - Abundant mRNA and protein levels in epidermal keratinocytes","volume":"89","author":"Ryyn\u00e4nen","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.11.023_bib32","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/sj.jid.5700117","article-title":"Fibroblasts show more potential as target cells than keratinocytes in COL7A1 gene therapy of dystrophic epidermolysis bullosa","volume":"126","author":"Goto","year":"2006","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ymthe.2025.11.023_bib33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41589-022-01163-8","article-title":"Engineering a precise adenine base editor with minimal bystander editing","volume":"19","author":"Chen","year":"2023","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ymthe.2025.11.023_bib34","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1016\/j.cell.2022.09.026","article-title":"Structural basis for Cas9 off-target activity","volume":"185","author":"Pacesa","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.11.023_bib35","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.stem.2021.02.002","article-title":"Quantitative evaluation of chromosomal rearrangements in gene-edited human stem cells by CAST-Seq","volume":"28","author":"Turchiano","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2025.11.023_bib36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41467-018-07988-z","article-title":"Genome-wide profiling of adenine base editor specificity by EndoV-seq","volume":"10","author":"Liang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.11.023_bib37","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1038\/mt.2014.187","article-title":"Long-Term Skin Regeneration From a Gene-Targeted Human Epidermal Stem Cell Clone","volume":"22","author":"Duarte","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.11.023_bib38","doi-asserted-by":"crossref","first-page":"380","DOI":"10.15252\/emmm.201404353","article-title":"A single epidermal stem cell strategy for safe ex vivo gene therapy","volume":"7","author":"Droz-Georget Lathion","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2025.11.023_bib39","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/sj.mt.6300238","article-title":"Long-term engraftment of single genetically modified human epidermal holoclones enables safety pre-assessment of cutaneous gene therapy","volume":"15","author":"Larcher","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.11.023_bib40","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2133.2010.09713.x","article-title":"The first COL7A1 mutation survey in a large Spanish dystrophic epidermolysis bullosa cohort: C.6527insC disclosed as an unusually recurrent mutation","volume":"163","author":"Esc\u00e1mez","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ymthe.2025.11.023_bib41","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s40265-023-01921-5","article-title":"Beremagene Geperpavec: First Approval","volume":"83","author":"Dhillon","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.ymthe.2025.11.023_bib42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1089\/crispr.2019.0017","article-title":"BEAT: A Python Program to Quantify Base Editing from Sanger Sequencing","volume":"2","author":"Xu","year":"2019","journal-title":"CRISPR J."},{"key":"10.1016\/j.ymthe.2025.11.023_bib43","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.ymthe.2024.03.006","article-title":"On- and off-target effects of paired CRISPR-Cas nickase in primary human cells","volume":"32","author":"Klermund","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.11.023_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177527","article-title":"Nonsense variant in COL7A1 causes recessive dystrophic epidermolysis bullosa in Central Asian Shepherd dogs","volume":"12","author":"Niskanen","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.11.023_bib45","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/01.TP.0000112381.80964.85","article-title":"Human plasma as a dermal scaffold for the generation of a completely autologous bioengineered skin","volume":"77","author":"Llames","year":"2004","journal-title":"Transplantation"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625009621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625009621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:33:16Z","timestamp":1775057596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625009621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1525001625009621"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.11.023","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Base edited skin equivalents with clinical potential for ex vivo correction of recessive dystrophic epidermolysis bullosa","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}